Here's what might work for youand what might be dangerous
Venting Gastrostomy or Jejunostomy In patients with significant upper GI motility disorders, surgically placed venting gastrostomy, with or without a venting enterostomy, has been found to reduce hospitalizations
#ObesityManagement #GLP1 #Endocrinology #Pharmacology #FDAApproval #WeightLoss #IncretinTherapy #ClinicalUpdates #HealthcareInnovation MBBS, MD, FICD, CCIGC | Physician & Medical Educator | Founder of @dr.pharmaxx94 (16k+ Instagram | 3K+ LinkedIn community) | Evidence-based medicine & public health communication Major FDA Approval (April 2026): A Turning Point in Obesity Management The Orforglipron has been approved by the U.S
These meds have plenty of room left to run
Hence, both bioavailable ferroptosis inhibitors and inducers are highly desirable for treating human diseases
Patients taking these medications saw a 12% to 14% drop in major heart events